Entry into a Material Definitive Agreement

Business Context and Reporting Period

This Form 8-K is filed by Viewbix Inc. (not Quantum X Labs Inc., as indicated in the metadata) for the reporting period ending July 30, 2024. The registrant is a Delaware corporation headquartered in Tel Aviv, Israel. The filing primarily reports on a strategic securities exchange agreement and the establishment of new credit facilities.

Key Financial Metrics and Agreements

The filing details significant capital structure changes rather than operational financial performance metrics (revenue, profit, or cash flow are not reported in this document).

  • Strategic Investment: Viewbix agreed to issue 9.99% of its outstanding capital stock in exchange for a 19.99% stake in Metagramm Software Ltd., an AI and natural language processing company.
  • Second Credit Facility: An amended $2.5 million facility with a term extending to 36 months or until a $2.0 million financing transaction is completed.
  • Third Credit Facility: A new $3.0 million credit facility established on July 28, 2024.
  • Interest Rate: The Third Credit Facility accrues interest at 12% per annum.
  • Conversion Terms: Interest and principal portions of the Third Facility may be converted into common stock at a rate of $0.25 per share (pre-reverse stock split basis).
  • One-Time Fee: The Company agreed to issue 600,000 shares of common stock as a fee to a Third Facility Lender.

Material Changes

Compared to prior periods, the Company has entered into material definitive agreements that alter its capital structure and debt obligations:

  • Equity Dilution: The issuance of 9.99% of Viewbix's stock to acquire a stake in Metagramm represents a significant change in ownership structure.
  • Debt Expansion: The Company has secured an additional $3.0 million in credit availability (Third Facility) and extended the terms of its existing $2.5 million facility (Second Facility).
  • Contingent Obligations: New obligations include the issuance of warrants and potential stock conversions tied to the "Uplist" (uplisting of shares to a national securities exchange).

Outlook, Risks, and Contingencies

Management Commentary and Strategy: The acquisition of Metagramm is driven by anticipated synergies in R&D and sales/marketing. The credit facilities are structured to support operations until a specific financing milestone ($2.0 million or $2.5 million fundraise) or an uplisting event occurs.

Risks and Contingencies:

  • Repayment Triggers: The Third Facility Loan Amount must be repaid immediately if the facility term lapses (40 months) without the completion of a $2.5 million fundraise.
  • Uplisting Dependency: Certain drawdowns and automatic conversions of debt to equity are contingent upon the effectiveness of an uplisting of the Company's shares.
  • Unregistered Securities: Securities issued under these agreements are unregistered under the Securities Act of 1933 and rely on Regulation S exemptions; they cannot be sold in the U.S. absent registration.

Investor Verification Checklist

  • Verify the exact terms of the Securities Exchange Agreement with Metagramm (Exhibit 10.1) to understand the valuation and governance implications of the 19.99% stake.
  • Confirm the status of the "Uplist" event, as it triggers automatic debt conversion and additional drawdowns.
  • Review the Third Facility Agreement (Exhibit 10.3) for specific covenants and the calculation of the 12% interest payable in stock or warrants.
  • Assess the Company's ability to raise the required $2.0 million or $2.5 million to prevent immediate debt repayment obligations.
  • Check for any pending registration statements filed within 30 days of July 28, 2024, as required for the resale of underlying securities.
Disclaimer:
This AI-generated summary by MetaQuotes is based on SEC filings and may contain errors. Verify important details against the original SEC filings.